메뉴 건너뛰기




Volumn 27, Issue 36, 2009, Pages 6079-6085

Hodgkin's lymphoma in adolescents treated with adult protocols: A report from the German Hodgkin study group

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

EID: 74949104363     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.20.2655     Document Type: Article
Times cited : (48)

References (31)
  • 1
    • 45149089132 scopus 로고    scopus 로고
    • Hodgkin's lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up
    • suppl 2
    • Engert A, Dreyling M: Hodgkin's lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19:ii65-ii66, 2008 (suppl 2)
    • (2008) Ann Oncol , vol.19
    • Engert, A.1    Dreyling, M.2
  • 2
    • 33750837637 scopus 로고    scopus 로고
    • Combined modality treatment of two or four cycles of ABVD followed by involved field radiotherapy in the treatment of patients with early stage Hodgkin's lymphoma: Update interim analysis of the randomised HD10 study of the German Hodgkin Study Group (GHSG)
    • abstr
    • Engert A, Pluetschow A, Eich HT, et al: Combined modality treatment of two or four cycles of ABVD followed by involved field radiotherapy in the treatment of patients with early stage Hodgkin's lymphoma: Update interim analysis of the randomised HD10 study of the German Hodgkin Study Group (GHSG). Blood 106:2673a, 2005 (abstr)
    • (2005) Blood , vol.106
    • Engert, A.1    Pluetschow, A.2    Eich, H.T.3
  • 3
    • 35848959692 scopus 로고    scopus 로고
    • Chemotherapy plus involved-field radiation in earlystage Hodgkin's disease
    • Fermé C, Eghbali H, Meerwaldt JH, et al: Chemotherapy plus involved-field radiation in earlystage Hodgkin's disease. N Engl J Med 357:1916-1927, 2007
    • (2007) N Engl J Med , vol.357 , pp. 1916-1927
    • Fermé, C.1    Eghbali, H.2    Meerwaldt, J.H.3
  • 4
    • 0141939066 scopus 로고    scopus 로고
    • Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with earlystage unfavorable Hodgkin's lymphoma: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group
    • Engert A, Schiller P, Josting A, et al: Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with earlystage unfavorable Hodgkin's lymphoma: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group. J Clin Oncol 21:3601-3608, 2003
    • (2003) J Clin Oncol , vol.21 , pp. 3601-3608
    • Engert, A.1    Schiller, P.2    Josting, A.3
  • 5
    • 24944453433 scopus 로고    scopus 로고
    • Comparison of BEACOPP and ABVD chemotherapy in intermediate stage Hodgkin's lymphoma: Results of the fourth interim analysis of the HD 11 trial of the GHSG
    • suppl 16S; abstr 6507, 561s
    • Klimm B, Engert A, Brillant C, et al: Comparison of BEACOPP and ABVD chemotherapy in intermediate stage Hodgkin's lymphoma: Results of the fourth interim analysis of the HD 11 trial of the GHSG. J Clin Oncol 23:561s, 2005 (suppl 16S; abstr 6507)
    • (2005) J Clin Oncol , vol.23
    • Klimm, B.1    Engert, A.2    Brillant, C.3
  • 6
    • 0026439199 scopus 로고
    • Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD
    • Canellos GP, Anderson JR, Propert KJ, et al: Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 327:1478-1484, 1992
    • (1992) N Engl J Med , vol.327 , pp. 1478-1484
    • Canellos, G.P.1    Anderson, J.R.2    Propert, K.J.3
  • 7
    • 0037567428 scopus 로고    scopus 로고
    • Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease
    • Diehl V, Franklin J, Pfreundschuh M, et al: Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. N Engl J Med 348:2386-2395,2003
    • (2003) N Engl J Med , vol.348 , pp. 2386-2395
    • Diehl, V.1    Franklin, J.2    Pfreundschuh, M.3
  • 8
    • 0344771027 scopus 로고    scopus 로고
    • High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: The German-Austrian multicenter trial DAL-HD-90-The German-Austrian Pediatric Hodgkin's Disease Study Group
    • Schellong G, Potter R, Bramswig J, et al: High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: The German-Austrian multicenter trial DAL-HD-90-The German-Austrian Pediatric Hodgkin's Disease Study Group. J Clin Oncol 17:3736-3744, 1999
    • (1999) J Clin Oncol , vol.17 , pp. 3736-3744
    • Schellong, G.1    Potter, R.2    Bramswig, J.3
  • 9
    • 16544364620 scopus 로고    scopus 로고
    • Riskadapted, combined-modality therapy with VAMP/ COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease
    • Hudson MM, Krasin M, Link MP, et al: Riskadapted, combined-modality therapy with VAMP/ COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. J Clin Oncol 22:4541-4550, 2004
    • (2004) J Clin Oncol , vol.22 , pp. 4541-4550
    • Hudson, M.M.1    Krasin, M.2    Link, M.P.3
  • 10
    • 33846903567 scopus 로고    scopus 로고
    • Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease
    • Donaldson SS, Link MP, Weinstein HJ, et al: Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. J Clin Oncol 25: 332-337, 2007
    • (2007) J Clin Oncol , vol.25 , pp. 332-337
    • Donaldson, S.S.1    Link, M.P.2    Weinstein, H.J.3
  • 11
    • 0038459195 scopus 로고    scopus 로고
    • Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: Analysis and outlook
    • Dörffel W, Luders H, Ruhl U, et al: Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: Analysis and outlook. Klin Padiatr 215: 139-145, 2003
    • (2003) Klin Padiatr , vol.215 , pp. 139-145
    • Dörffel, W.1    Luders, H.2    Ruhl, U.3
  • 12
    • 10744222812 scopus 로고    scopus 로고
    • Importance of F18-fluorodeoxy-D-2-glucose positron emission tomography (FDG-PET) for staging and therapy control of Hodgkin's lymphoma in childhood and adolescence: Consequences for the GPOH-HD 2003 protocol
    • Körholz D, Kluge R, Wickmann L, et al: Importance of F18-fluorodeoxy-D-2-glucose positron emission tomography (FDG-PET) for staging and therapy control of Hodgkin's lymphoma in childhood and adolescence: Consequences for the GPOH-HD 2003 protocol. Onkologie 26:489-493, 2003
    • (2003) Onkologie , vol.26 , pp. 489-493
    • Körholz, D.1    Kluge, R.2    Wickmann, L.3
  • 13
    • 34247379458 scopus 로고    scopus 로고
    • Adolescents with Hodgkin lymphoma treated on adult and pediatric protocols have distinct therapeutic outcome
    • abstr
    • Mottl AA, Fisher SG, Fisher RI, et al: Adolescents with Hodgkin lymphoma treated on adult and pediatric protocols have distinct therapeutic outcome. Blood 104:312, 2004 (abstr)
    • (2004) Blood , vol.104 , pp. 312
    • Mottl, A.A.1    Fisher, S.G.2    Fisher, R.I.3
  • 14
    • 0032548107 scopus 로고    scopus 로고
    • A prognostic score for advanced Hodgkin's disease: International Prognostic Factors Project on Advanced Hodgkin's Disease
    • Hasenclever D, Diehl V: A prognostic score for advanced Hodgkin's disease: International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 339:1506-1514, 1998
    • (1998) N Engl J Med , vol.339 , pp. 1506-1514
    • Hasenclever, D.1    Diehl, V.2
  • 15
    • 0037080280 scopus 로고    scopus 로고
    • Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediatestage Hodgkin's lymphoma: Final results of the German Hodgkin's Lymphoma Study Group Trial HD5
    • Sieber M, Tesch H, Pfistner B, et al: Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediatestage Hodgkin's lymphoma: Final results of the German Hodgkin's Lymphoma Study Group Trial HD5. J Clin Oncol 20:476-484, 2002
    • (2002) J Clin Oncol , vol.20 , pp. 476-484
    • Sieber, M.1    Tesch, H.2    Pfistner, B.3
  • 16
    • 8044250873 scopus 로고    scopus 로고
    • BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease-The German Hodgkin's Lymphoma Study Group
    • Diehl V, Sieber M, Ruffer U, et al: BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease-The German Hodgkin's Lymphoma Study Group. Ann Oncol 8:143-148, 1997
    • (1997) Ann Oncol , vol.8 , pp. 143-148
    • Diehl, V.1    Sieber, M.2    Ruffer, U.3
  • 17
    • 0035367817 scopus 로고    scopus 로고
    • Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: Long-term results of a randomized trial of radiotherapy alone
    • Dühmke E, Franklin J, Pfreundschuh M, et al: Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: Long-term results of a randomized trial of radiotherapy alone. J Clin Oncol 19:2905-2914, 2001
    • (2001) J Clin Oncol , vol.19 , pp. 2905-2914
    • Dühmke, E.1    Franklin, J.2    Pfreundschuh, M.3
  • 18
    • 34548186696 scopus 로고    scopus 로고
    • Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: Final results of the GHSG HD7 trial
    • Engert A, Franklin J, Eich HT, et al: Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: Final results of the GHSG HD7 trial. J Clin Oncol 25:3495-3502, 2007
    • (2007) J Clin Oncol , vol.25 , pp. 3495-3502
    • Engert, A.1    Franklin, J.2    Eich, H.T.3
  • 19
    • 10744224542 scopus 로고    scopus 로고
    • Treatment of advanced Hodgkin's disease with COPP/ ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: Final results of the German Hodgkin's Lymphoma Study Group HD6 trial
    • Sieber M, Tesch H, Pfistner B, et al: Treatment of advanced Hodgkin's disease with COPP/ ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: Final results of the German Hodgkin's Lymphoma Study Group HD6 trial. Ann Oncol 15: 276-282, 2004
    • (2004) Ann Oncol , vol.15 , pp. 276-282
    • Sieber, M.1    Tesch, H.2    Pfistner, B.3
  • 20
    • 84871466804 scopus 로고    scopus 로고
    • Statistisches Bundesamt Deutschland
    • Statistisches Bundesamt Deutschland: Tables [inGerman].http://www. destatis.de/jetspeed/portal/cms/Sites/destatis/Internet/DE/Navigation/ Statistiken/Bevoelkerung/GeburtenSterbefaelle/Tabellen.psml
    • Tables [inGerman]
  • 21
    • 84871466037 scopus 로고    scopus 로고
    • Glasmacher S: Cancer in Germany 2003-2004: Frequency and trends [in German]. http://idwonline.de/pages/de/news?print=1&id=247547
    • Glasmacher S: Cancer in Germany 2003-2004: Frequency and trends [in German]. http://idwonline.de/pages/de/news?print=1&id=247547
  • 23
    • 0028003711 scopus 로고
    • Hodgkin's disease in children in the West Midlands, 1957-1986: A large population-based study
    • Parkes SE, Coad NA, Muir KR, et al: Hodgkin's disease in children in the West Midlands, 1957-1986: A large population-based study. Pediatr Hematol Oncol 11:471-486, 1994
    • (1994) Pediatr Hematol Oncol , vol.11 , pp. 471-486
    • Parkes, S.E.1    Coad, N.A.2    Muir, K.R.3
  • 25
    • 3042731977 scopus 로고    scopus 로고
    • Long term outcome in adolescents with Hodgkin's lymphoma: Poor results using regimens designed for adults
    • Yung L, Smith P, Hancock BW, et al: Long term outcome in adolescents with Hodgkin's lymphoma: Poor results using regimens designed for adults. Leuk Lymphoma 45:1579-1585, 2004
    • (2004) Leuk Lymphoma , vol.45 , pp. 1579-1585
    • Yung, L.1    Smith, P.2    Hancock, B.W.3
  • 26
    • 51049095165 scopus 로고    scopus 로고
    • Poor outcome in adolescents with high-risk Hodgkin lymphoma
    • Herbertson RA, Evans LS, Hutchinson J, et al: Poor outcome in adolescents with high-risk Hodgkin lymphoma. Int J Oncol 33:145-151, 2008
    • (2008) Int J Oncol , vol.33 , pp. 145-151
    • Herbertson, R.A.1    Evans, L.S.2    Hutchinson, J.3
  • 27
    • 0033952110 scopus 로고    scopus 로고
    • Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood
    • van Leeuwen FE, Klokman WJ, Veer MB, et al: Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 18:487-497, 2000
    • (2000) J Clin Oncol , vol.18 , pp. 487-497
    • van Leeuwen, F.E.1    Klokman, W.J.2    Veer, M.B.3
  • 28
    • 0037102360 scopus 로고    scopus 로고
    • Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years
    • Dores GM, Metayer C, Curtis RE, et al: Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years. J Clin Oncol 20:3484-3494, 2002
    • (2002) J Clin Oncol , vol.20 , pp. 3484-3494
    • Dores, G.M.1    Metayer, C.2    Curtis, R.E.3
  • 29
    • 0142058040 scopus 로고    scopus 로고
    • Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: A report from the German Hodgkin's Lymphoma Study Group
    • Josting A, Wiedenmann S, Franklin J, et al: Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: A report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol 21:3440-3446, 2003
    • (2003) J Clin Oncol , vol.21 , pp. 3440-3446
    • Josting, A.1    Wiedenmann, S.2    Franklin, J.3
  • 30
    • 0035300679 scopus 로고    scopus 로고
    • Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: Incidence, treatment, and prognosis
    • Rueffer U, Josting A, Franklin J, et al: Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: Incidence, treatment, and prognosis. J Clin Oncol 19:2026-2032, 2001
    • (2001) J Clin Oncol , vol.19 , pp. 2026-2032
    • Rueffer, U.1    Josting, A.2    Franklin, J.3
  • 31
    • 32144439729 scopus 로고    scopus 로고
    • Acute myeloid leukemia following Hodgkin lymphoma: A population-based study of 35,511 patients
    • Schonfeld SJ, Gilbert ES, Dores GM, et al: Acute myeloid leukemia following Hodgkin lymphoma: A population-based study of 35,511 patients. J Natl Cancer Inst 98:215-218, 2006
    • (2006) J Natl Cancer Inst , vol.98 , pp. 215-218
    • Schonfeld, S.J.1    Gilbert, E.S.2    Dores, G.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.